Before joining Reed Exhibitions in 2016, Kumsal was RELX Chief Strategy Officer, responsible for driving strategic initiatives, technology strategy and portfolio management. Prior to that she served in several operational and strategic roles with LexisNexis. Kumsal also chairs the Technology Forum at RELX. Prior to joining RELX Group in 2004, Kumsal spent several years at Bain & Company in their New York, Los Angeles, Johannesburg and Sydney offices. Kumsal earned an MBA from Harvard Business School and is a graduate of University of California at Berkeley where she received a Bachelor’s degree in Economics with honors.

He has received honorary doctorates in medicine from the University of Birmingham, UK, and the Universities of Gothenburg and Umea in Sweden. In 2016, he was appointed to the High-Level Working Group for the Health and Human Rights of Women, Children, and Adolescents. In 2016, he also chaired the Expert Group for the High Level Commission on Health Employment and Economic Growth, convened by Presidents Hollande of France and Zuma of South Africa. From 2011 to 2015, he was co-chair of the UN's independent Expert Review Group on Information and Accountability for Women's and Children's Health. Richard received the Edinburgh Medal in 2007 and the Dean’s Medal from Johns Hopkins School of Public Health in 2009. In 2016, he was awarded an Honorary Fellowship by the British Pharmacological Society. He has written two reports for the Royal College of Physicians of London: Doctors in Society (2005) and Innovating for Health (2009). He wrote Health Wars (2003) about contemporary issues in medicine and health, and he has written for The New York Review of Books and the TLS. He has a strong interest in global health and medicine’s contribution to our wider culture. He now works to develop the idea of planetary health – the health of human civilizations and the ecosystems on which they depend. In 2011, he was elected a Foreign Associate of the US Institute of Medicine. In 2015, he received the Friendship Award from the Government of China. In 2016, he received the Andrija Stamper medal from the Association of Schools of Public Health in the European region and in 2017, he was awarded the Edwin Chadwick Medal for outstanding contributions to the advancement of public health.

Prior to this role, he served as BMGF Director of Family Health, leading strategy development and implementation across nutrition, family planning and maternal, newborn and child health. Darmstadt was formerly Associate Professor and Founding Director of the International Center for Advancing Neonatal Health in the Department of International Health at the Johns Hopkins School of Public Health. He has trained in Pediatrics at Johns Hopkins University, in Dermatology at Stanford University, and in Pediatric Infectious Disease as a fellow at the University of Washington, Seattle, where he was Assistant Professor in the Departments of Pediatrics and Medicine. Dr. Darmstadt also served as Senior Research Advisor for the Saving Newborn Lives program of Save the Children-US, where he led the development and implementation of the global research strategy for newborn health and survival.

She has lived and worked for much of the past 25 years in Asia, where she has gathered evidence, collaborated to strengthen capacity, and operated at the interface of policy and research communities – working alongside national Governments, UN agencies and civil society organisations promoting gender, equity, equality and human rights in health policies and programmes.

She has conducted research on health policy and health systems in Europe, Sub-Saharan Africa and currently with a focus on Southeast Asia. Specific areas of expertise include gender equality, migrant health, global health governance, and health systems resilience. Specific research with a gender lens includes studies on gender equality in global health, gender and ethnic diversity in leading public health universities, gender equality and leadership in the nursing profession, and gender differences in the utilization of services. She has published over 100 articles in peer reviewed journals. Her work has been published in journals such as the Lancet, British Medical Journal and PLOS Medicine. It has also been widely covered in International media including The Times, The Economist, the Financial Times and the Huffington Post.

She moved to Imperial College University of London, first to the School of Management and then to the Department of Computing, where she spent over 20 years as researcher and lecturer. In 2001 together with a group of women scientists and engineers at Imperial College she set up Portia a not-for-profit organisation focused on improving gender equality in science practice and integration of gender dimension in science knowledge.  She coordinated a number of European and international projects, notably the UK Tri-Council Initiative on Cognitive Science and Human-Computer Interactions; the FP7 funded genSET project; and two projects dedicated to women’s early science career stage issues, one funded by the Elsevier Foundation and the other by the Robert Bosch Foundation. She acts as expert adviser to the European Commission, and was involved in several European projects: GenPORT, GENERA, NAPES, and currently in ACT.  She is also responsible for the coordination, organization, and global development of the Gender Summit platform, which brings scientists, gender scholars and policy makers together to examine research evidence showing the influence of sex-gender factors in research results and in outcomes for women and men, and establish consensus on where improvements are needed and what actions will achieve change.

Prof. Schiebinger received her PhD from Harvard University in 1984 and is a leading international authority on gender and science. Over the past 30 years, Dr. Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.

Dr. Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the finding at the United Nations in New York, February 2011 with an update spring 2014. In 2011-2012 and 2018-2020, Dr. Schiebinger entered into major collaborations with the European Union to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the US, Europe, Canada, Asia and now Latin America and was presented at the European Parliament in July 2013.

Her research currently focuses on the integration of different perspectives in the innovation process and involvement of potential users, dialogue between different science disciplines, and accommodating views of different stakeholders. Prof. Schraudner is a member of the genSET Science Leaders Panel; the Gender Summits were established on the recommendation of the panel.

Citing NIH Director Dr. Francis Collins’ statement about Dr. Valantine’s accomplishments at NIH, “her laser-like focus on expanding recruitment and retention of the brightest minds regardless of race, ethnicity, gender, disability, and socioeconomic status has produced remarkable results over a few short years.” For example, she established the Distinguished Scholars Program, which has had a dramatic, positive impact on the diversity of tenure-track investigators at NIH. Hannah established the NIH Equity Committee to systematically track and evaluate diversity and inclusion metrics in each NIH Institute and Center’s intramural program. Under her leadership, there has been a significant increase in representation of women as tenure-track and tenured principal investigators (PI), and of African American/Black and Hispanic tenure-track PIs in the Intramural Program. There also has been a significant increase in representation of women in NIH leadership positions, such as Institute/Center Directors and Scientific Directors. she played a major role in taking on workplace harassment at NIH. One of her significant achievements was developing and implementing the first NIH Workplace Climate and Harassment Survey. The findings provided critical data that have informed NIH’s strategies to improve the workplace moving forward. The survey provides a tool (now published) for NIH-funded institutions across the country to assess and improve their workplace climates.

The impact of Dr. Valantine’s work has been felt well beyond the NIH campus. She has made several important inroads into improving diversity and equity among the extramural research community. For example, Hannah designed the Faculty Institutional Recruitment for Sustainable Transformation (FIRST) program that is being implemented by the NIH Common Fund to create cultures of inclusive excellence at NIH-funded institutions. She also guided the National Research Mentoring Network program on coaching and mentoring for grant writing toward successful applications and awards supporting scientists from diverse backgrounds, including those from underrepresented racial and ethnic groups. Since her arrival at NIH, there has been a significant increase in the number of R01 applications and awards that identify African American/Black and Hispanic scientists as the Program Director/Principal Investigator (PD/PI). And for early career scientists, she has focused on career development awards (K-series), the penultimate stage before R01 grants, increasing the number of applications and awards on which African American/Black and Hispanic scientists are identified as PD/PIs, essentially eliminating the racial gap in success rates for K-awards.

At NIH Dr. Valantine established a highly productive research program within the National Heart, Lung, and Blood Institute (NHLBI). She created the Genomic Research Alliance for Transplantation (GRAfT), a consortium of five heart and lung transplant programs in the Washington, D.C. metropolitan area, which has enrolled and is actively following more than 500 patients, 40% of whom are African American/Black. She is using the technology that she co-invented with Steve Quake, professor bioengineering at Stanford — donor-derived cell-free DNA in blood — to monitor organ transplant rejection in the GRAfT cohort, and to understand the mechanisms that explain how and why African Americans/Blacks reject their organ transplants at higher rates than White recipients.

Dr. Valantine was elected to National Academy of Medicine in 2020, “for her national leadership in both scientific workforce diversity and cardiac transplantation research. Her data-driven approach in these two important areas has led to game-changing policies and new programs that enriched the nation’s biomedical talent pool and have generated paradigm-shifting innovations in patient care.”

She also worked as Council Member of Science and Technology Council at Ministry of Education, Culture, Sports, Science and Technology from 2012 to 2017, as Chairperson of Japan Women Engineers Forum from 2012 to 2014, and as Auditor at National Institute for Environmental Studies in Japan from 2013 to 2015.

She has also been Council Member of Science Council of Japan (SCJ) since 2011, and Vice-president of SCJ in charge of science and society since October 2017. She worked as Chair of Committee on Comprehensive and Synthetic Engineering in SCJ from 2014 to 2017. Dr. Watanabe has been a member of Specialist Committee on Priority Policy in Council for Gender Equality of Cabinet Office of Japan since 2014. She was the chair of both Science Agora in 2015 and 2016 and Gender Summit 10 in Tokyo in 2017.　She was also appointed STEM girls ambassador by Cabinet office in June, 2018, and has been active to promote STEM girls activity.

Welton's research focuses on sustainable chemistry, and involves ionic liquids – chemicals that provide hope for replacing solvents that are used to dissolve materials but are often hazardous to health and the environment. As well as studying how they behave, he works on practical applications of future ionic liquid solvents, such as for dissolving textiles to make them more readily recyclable and for dissolving wood to create biofuels.

Under Professor Welton’s leadership as Head of Chemistry at Imperial, the department was awarded an Athena SWAN Gold Award in recognition of efforts to promote women in science – one of only four awarded in the country at the time. He has also been appointed to the UKRI Equality, Diversity and Inclusion External Advisory Group and in 2017 was awarded an OBE for services to diversity in education.

She continued her postdoctoral training at Princeton University, focusing on the structural characterization of intramembrane proteases. In 2007, she joined the faculty of School of Medicine, Tsinghua University. Her lab has been mainly focusing on the structural and functional study of membrane transport proteins exemplified by the glucose transporters and Na⁺/Ca²⁺ channels. In 2012 and 2013, she was promoted to tenured professor and Bayer Endowed Chair Professor, respectively. Dr. Yan was an HHMI international early career scientist in 2012-2017, the recipient of the 2015 Protein Society Young Investigator Award and the 2015 Beverley & Raymond Sackler International Prize in Biophysics, and the Alexander M. Cruickshank lecturer at the GRC on membrane transport proteins in 2016.